Literature DB >> 20096461

Effects of transmembrane and juxtamembrane domains on proliferative ability of TSLP receptor.

Jun Zhong1, Xuedong Liu, Akhilesh Pandey.   

Abstract

Thymic stromal lymphopoietin (TSLP) is an IL-7-like cytokine that requires a heterodimeric receptor complex composed of the interleukin-7 receptor alpha chain and the TSLP receptor, which is related to the common gamma chain. TSLP has been shown to play an important role in the development of allergic inflammation, such as asthma and atopic dermatitis. Chimeric receptors composed of the cytoplasmic region of the TSLP receptor fused to the extracellular regions of homodimeric receptors, such as erythropoietin (Epo) receptor and thrombopoietin receptor have been used to dissect signaling events induced by the TSLP receptor. Intriguingly, studies using such chimeric TSLP receptors revealed that the human, but not mouse, TSLP receptor cytoplasmic domain can support proliferation of growth factor-dependent cells after homodimerization. Here, we used a systematic approach to investigate the mechanistic basis of this difference. Our studies revealed that induced homodimerization of receptor chimeras containing the transmembrane and cytoplasmic domains of both human and mouse TSLP receptors is not sufficient for driving cell proliferation. However, chimeric receptors with the transmembrane and juxtamembrane domains of Epo receptor fused to the cytoplasmic domain of human TSLP receptor signal like the Epo receptor and induce the activation of Jak2. Site-directed mutagenesis showed that the lone tyrosine residue in human TSLP receptor is not required for transmitting proliferative signals in receptor chimeras, which is consistent with the observation that none of the tyrosine residues are required for Epo receptor to support proliferation. Our data suggests that in the chimeric receptor context, the transmembrane and juxtamembrane domains of mouse Epo receptor are essential for the cytoplasmic domain of human TSLPR to achieve the strong proliferative ability and can modulate signaling pathway transmitted by the cytoplasmic domains of these chimeras. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20096461     DOI: 10.1016/j.molimm.2009.12.017

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  3 in total

1.  Differences in signaling through the B-cell leukemia oncoprotein CRLF2 in response to TSLP and through mutant JAK2.

Authors:  Diederik van Bodegom; Jun Zhong; Nadja Kopp; Chaitali Dutta; Min-Sik Kim; Liat Bird; Oliver Weigert; Jeffrey Tyner; Akhilesh Pandey; Akinori Yoda; David M Weinstock
Journal:  Blood       Date:  2012-08-20       Impact factor: 22.113

2.  The extracellular and transmembrane domains of the γC and interleukin (IL)-13 receptor α1 chains, not their cytoplasmic domains, dictate the nature of signaling responses to IL-4 and IL-13.

Authors:  Nicola M Heller; Xiulan Qi; Franck Gesbert; Achsah D Keegan
Journal:  J Biol Chem       Date:  2012-07-24       Impact factor: 5.157

Review 3.  A molecular perspective on TH2-promoting cytokine receptors in patients with allergic disease.

Authors:  Martin J Romeo; Rachana Agrawal; Anna Pomés; Judith A Woodfolk
Journal:  J Allergy Clin Immunol       Date:  2013-09-29       Impact factor: 10.793

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.